ARCHIVES

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

This article is from The Cancer Letter archive.

Vol. 21 No. 38 | October 6, 1995

Download PDF Visit The Full Archive

Related Articles

NEJM Papers Reaffirm Results Of Lumpectomy Trial; Audit Verifies Data

December 8, 1995

Philadelphia Firm Wins CIDAC Award

August 24, 1984

NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said

June 24, 1994

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999

FDA Grants Accelerated Approval To Ferriprox for Iron Overload

October 28, 2011

NCI advisory panel recommends funding a 10-year Human Cancer Genome Project with $1.35 billion in new money.

March 18, 2005